Udayakumar Navaneethan1, Vennisvasanth Lourdusamy2,3, Basile Njei4, Bo Shen5. 1. Center for Interventional Endoscopy, Florida Hospital, 601 E Rollins Street, Orlando, FL, 32803, USA. udhaykumar81@gmail.com. 2. Center for Interventional Endoscopy, Florida Hospital, 601 E Rollins Street, Orlando, FL, 32803, USA. 3. Department of Internal Medicine, Brandon Regional Hospital, Brandon, FL, USA. 4. Section of Digestive Diseases, Yale University, New Haven, CT, USA. 5. Department of Gastroenterology, The Cleveland Clinic, Cleveland, OH, USA.
Abstract
BACKGROUND AND AIM: Crohn's disease (CD) is associated with strictures. Endoscopic balloon dilatation (EBD) may prevent or delay the need for surgical resection. The aim of this systematic review was to determine the efficacy and safety of EBD in the management of Crohn's strictures. METHODS: A comprehensive search of MEDLINE and EMBASE databases from January 1980 to May 2015 was performed. The primary outcome measurements were surgical intervention rates and major adverse events. RESULTS: A total of 24 studies involving 1163 patients were included in the analysis. The median duration from the initial diagnosis of CD to the first EBD was 10.2-17.0 years. The majority of strictures (69 %) treated were anastomotic, while the remaining strictures were naive (primary). Surgical intervention rate over a median follow-up period of 15-70 months in the reported studies was 27 %. The surgical intervention rate after dilation of anastomotic strictures was 18 % versus 29 % for primary strictures. The risk ratio for the surgical requirement of anastomotic versus primary strictures was [0.88 (95 % confidence interval [CI] 0.59-1.32); p = 0.54]. Stricture length <4 cm was associated with a significantly decreased risk of surgical intervention [risk ratio = 0.48 (95 % CI 0.26-0.90); p = 0.02]. EBD resulted in major adverse events in 4 % of the patients. CONCLUSIONS: EBD appears to be a safe alternative for surgery in the management of Crohn's strictures. Stricture length <4 cm treated with EBD is associated with a significantly decreased risk of surgical intervention.
BACKGROUND AND AIM: Crohn's disease (CD) is associated with strictures. Endoscopic balloon dilatation (EBD) may prevent or delay the need for surgical resection. The aim of this systematic review was to determine the efficacy and safety of EBD in the management of Crohn's strictures. METHODS: A comprehensive search of MEDLINE and EMBASE databases from January 1980 to May 2015 was performed. The primary outcome measurements were surgical intervention rates and major adverse events. RESULTS: A total of 24 studies involving 1163 patients were included in the analysis. The median duration from the initial diagnosis of CD to the first EBD was 10.2-17.0 years. The majority of strictures (69 %) treated were anastomotic, while the remaining strictures were naive (primary). Surgical intervention rate over a median follow-up period of 15-70 months in the reported studies was 27 %. The surgical intervention rate after dilation of anastomotic strictures was 18 % versus 29 % for primary strictures. The risk ratio for the surgical requirement of anastomotic versus primary strictures was [0.88 (95 % confidence interval [CI] 0.59-1.32); p = 0.54]. Stricture length <4 cm was associated with a significantly decreased risk of surgical intervention [risk ratio = 0.48 (95 % CI 0.26-0.90); p = 0.02]. EBD resulted in major adverse events in 4 % of the patients. CONCLUSIONS: EBD appears to be a safe alternative for surgery in the management of Crohn's strictures. Stricture length <4 cm treated with EBD is associated with a significantly decreased risk of surgical intervention.
Entities:
Keywords:
Crohn’s disease; Endoscopy; Inflammatory bowel disease; Strictures; Surgery
Authors: Klaus Stienecker; Daniel Gleichmann; Ulrike Neumayer; H Joachim Glaser; Carolin Tonus Journal: World J Gastroenterol Date: 2009-06-07 Impact factor: 5.742
Authors: Alexander F Hagel; Anna Hahn; Wolfgang Dauth; Klaus Matzel; Peter C Konturek; Markus F Neurath; Martin Raithel Journal: Surg Endosc Date: 2014-05-23 Impact factor: 4.584
Authors: A Ferlitsch; W Reinisch; A Püspök; C Dejaco; M Schillinger; R Schöfl; R Pötzi; A Gangl; H Vogelsang Journal: Endoscopy Date: 2006-05 Impact factor: 10.093
Authors: Mahesh Bhalme; Sanchoy Sarkar; Simon Lal; Keith Bodger; Rose Baker; Robert P Willert Journal: Inflamm Bowel Dis Date: 2014-02 Impact factor: 5.325
Authors: Christopher Andrew Lamb; Nicholas A Kennedy; Tim Raine; Philip Anthony Hendy; Philip J Smith; Jimmy K Limdi; Bu'Hussain Hayee; Miranda C E Lomer; Gareth C Parkes; Christian Selinger; Kevin J Barrett; R Justin Davies; Cathy Bennett; Stuart Gittens; Malcolm G Dunlop; Omar Faiz; Aileen Fraser; Vikki Garrick; Paul D Johnston; Miles Parkes; Jeremy Sanderson; Helen Terry; Daniel R Gaya; Tariq H Iqbal; Stuart A Taylor; Melissa Smith; Matthew Brookes; Richard Hansen; A Barney Hawthorne Journal: Gut Date: 2019-09-27 Impact factor: 23.059
Authors: Sara El Ouali; Benjamin Click; Stefan D Holubar; Florian Rieder Journal: United European Gastroenterol J Date: 2020-01-14 Impact factor: 4.623
Authors: Joseph Sleiman; Sara El Ouali; Taha Qazi; Benjamin Cohen; Scott R Steele; Mark E Baker; Florian Rieder Journal: Expert Rev Gastroenterol Hepatol Date: 2020-12-28 Impact factor: 3.869